Some students who started their MPharm degree at the University of Central Lancashire (UCLan) as part of the 2022/2023 cohort should not have been accepted onto the course because they "did not meet the identified academic requirements", the General Pharmaceutical Council (GPhC) has told The Pharmaceutical Journal.